NCT06331806View on ClinicalTrials.gov

Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Cardiomyopathy Due to Drug
Interventions
DIAGNOSTIC_TEST

Evaluation of myocardial fibrosis

echocardiogram with left ventricular ejection fraction (LVEF) evaluation (biplane method) and CMR with contrast media agent

Trial Locations (1)

Unknown

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER